And mice treated with dTCR-T cells plus DAC showed a higher proportion of activated CD3+CD25+ cells (Fig. 7C), CD8+ cells (Fig. 7D), and CD4+ cells (Fig. 7E) compared with the other groups, suggesting higher anti-leukemia activity. The gene discussed is CD8A; the disease is leukemia.